BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 2152835)

  • 1. Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication.
    Schaack J; Schedl P; Shenk T
    J Virol; 1990 Jan; 64(1):78-85. PubMed ID: 2152835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
    Wong ML; Hsu MT
    J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription of adenovirus and HeLa cell genes in the presence of drugs that inhibit topoisomerase I and II function.
    Schaak J; Schedl P; Shenk T
    Nucleic Acids Res; 1990 Mar; 18(6):1499-508. PubMed ID: 2158079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.
    Levac P; Moss T
    Chromosoma; 1996 Oct; 105(4):250-60. PubMed ID: 8854885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of topoisomerase I and II cleavage sites on the Drosophila actin and Hsp70 heat shock genes.
    Kroeger PE; Rowe TC
    Biochemistry; 1992 Mar; 31(9):2492-501. PubMed ID: 1312349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of VM26, a specific inhibitor of type II DNA topoisomerase, on SV40 chromatin replication in vitro.
    Richter A; Strausfeld U
    Nucleic Acids Res; 1988 Nov; 16(21):10119-29. PubMed ID: 2848217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the DNA topoisomerase II inhibitor, VM26, on transcriptional initiation in vitro.
    Preston GM; White BA
    Life Sci; 1990; 46(18):1309-18. PubMed ID: 2161065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerases I & II cleavage sites in the type 1 human immunodeficiency virus (HIV-1) DNA promoter region.
    Pommier Y; Poddevin B; Gupta M; Jenkins J
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1601-9. PubMed ID: 7811242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs.
    Pommier Y; Capranico G; Orr A; Kohn KW
    J Mol Biol; 1991 Dec; 222(4):909-24. PubMed ID: 1662289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replication in vivo.
    Richter A; Strausfeld U; Knippers R
    Nucleic Acids Res; 1987 Apr; 15(8):3455-68. PubMed ID: 3033604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of topoisomerase-specific antitumor drugs in human lymphocytes using rabbit antisera against recombinant human topoisomerase II polypeptide.
    Hwang JL; Shyy SH; Chen AY; Juan CC; Whang-Peng J
    Cancer Res; 1989 Feb; 49(4):958-62. PubMed ID: 2536295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
    Jaxel C; Kohn KW; Pommier Y
    Nucleic Acids Res; 1988 Dec; 16(23):11157-70. PubMed ID: 2849758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26.
    Minocha A; Long BH
    Biochem Biophys Res Commun; 1984 Jul; 122(1):165-70. PubMed ID: 6331440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5'-phosphorylated DNA double-strand breaks by replication runoff.
    Strumberg D; Pilon AA; Smith M; Hickey R; Malkas L; Pommier Y
    Mol Cell Biol; 2000 Jun; 20(11):3977-87. PubMed ID: 10805740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase II cleavage of herpes simplex virus type 1 DNA in vivo is replication dependent.
    Ebert SN; Shtrom SS; Muller MT
    J Virol; 1990 Sep; 64(9):4059-66. PubMed ID: 2166804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antitumor drug-induced topoisomerase cleavage complex blocks a bacteriophage T4 replication fork in vivo.
    Hong G; Kreuzer KN
    Mol Cell Biol; 2000 Jan; 20(2):594-603. PubMed ID: 10611238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of topoisomerases I and II arrest DNA replication, but do not prevent nucleosome assembly in vivo.
    Annunziato AT
    J Cell Sci; 1989 Aug; 93 ( Pt 4)():593-603. PubMed ID: 2558122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1.
    Ebert SN; Subramanian D; Shtrom SS; Chung IK; Parris DS; Muller MT
    J Virol; 1994 Feb; 68(2):1010-20. PubMed ID: 8289331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the type I DNA topoisomerase gene in adenovirus-5 infected human cells.
    Romig H; Richter A
    Nucleic Acids Res; 1990 Feb; 18(4):801-8. PubMed ID: 2156232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
    Andrea JE; Adachi K; Morgan AR
    Mol Pharmacol; 1991 Oct; 40(4):495-501. PubMed ID: 1656189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.